Discover how synthetic T-cell receptor-like proteins behave as Janus particles in solution, revolutionizing cancer treatment and protein engineering.
For patients with MUC16-positive cancers, a new targeted therapy offers a beacon of hope by turning a tumor marker into a bullseye.
Discover how regional administration of IL-12 endowed CAR T-cells effectively targets systemic cancer through innovative immunotherapy approaches.
Discover how scientists are engineering bispecific antibodies - revolutionary proteins that can target cancer cells and immune cells simultaneously.
Discover how polymer modification through hydrophilization is transforming cancer treatment by making anti-cancer drugs more targeted and less toxic.
Explore how the measles virus is being transformed into a revolutionary cancer treatment through oncolytic virotherapy, targeting tumors while sparing healthy tissue.
Explore how scientists are engineering T cell receptors to optimize recognition of target antigens, revolutionizing cancer treatment and immunotherapy.
Discover how engineered platelets delivering PD-1 immunotherapy are transforming post-surgery cancer treatment with targeted precision.